| Date | Time | Local Time | Room | Session | Role | Topic |
|---|---|---|---|---|---|---|
| 2024-11-29 | 17:30-17:35 | 2024-11-29,17:30-17:35 | Poster Area |
Moderated ePoster Presentation P04 | Organ Damage and Co-morbidities |
Speaker | The Net Clinical Benefit of Fondaparinux vs LMWH in Chinese Non-ST-Segment Elevation Acute Coronary Syndrome Patients: the REFOCAS Nonrandomized Controlled Trial |
| - | ,- |